Nektar Therapeutics (NASDAQ:NKTR)

14.41
Data as of Aug 26
 +0.18 / +1.26%
Today’s Change
8.87
Today|||52-Week Range
15.34
+26.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.8B

Company Description

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. These technology platforms are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient. Nektar Therapeutics was founded in 1990 and is headquartered in San Francisco, CA.

Contact Information

Nektar Therapeutics
455 Mission Bay Boulevard South
San Francisco California 94158
P:(415) 482-5300
Investor Relations:
(415) 482-5593

Employees

Shareholders

Mutual fund holders72.08%
Other institutional18.07%
Individual stakeholders1.88%

Top Executives

Howard W. RobinPresident, Chief Executive Officer & Director
John NicholsonChief Financial Officer & Senior Vice President
Stephen K. DobersteinChief Scientific Officer & Senior Vice President
Ivan P. GergelChief Medical Officer & SVP-Drug Development
Gilbert M. LabrucherieSecretary, Senior Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.